Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial
Overview
Authors
Affiliations
Background: In ISCHEMIA-CKD, 777 patients with advanced chronic kidney disease and chronic coronary disease had similar all-cause mortality with either an initial invasive or conservative strategy (27.2% vs 27.8%, respectively).
Objectives: This prespecified secondary analysis from ISCHEMIA-CKD (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Chronic Kidney Disease) was conducted to determine whether an initial invasive strategy compared with a conservative strategy decreased the incidence of cardiovascular (CV) vs non-CV causes of death.
Methods: Three-year cumulative incidences were calculated for the adjudicated cause of death. Overall and cause-specific death by treatment strategy were analyzed using Cox models adjusted for baseline covariates. The association between cause of death, risk factors, and treatment strategy were identified.
Results: A total of 192 of the 777 participants died during follow-up, including 94 (12.1%) of a CV cause, 59 (7.6%) of a non-CV cause, and 39 (5.0%) of an undetermined cause. The 3-year cumulative rates of CV death were similar between the invasive and conservative strategies (14.6% vs 12.6%, respectively; HR: 1.13, 95% CI: 0.75-1.70). Non-CV death rates were also similar between the invasive and conservative arms (8.4% and 8.2%, respectively; HR: 1.25; 95% CI: 0.75-2.09). Sudden cardiac death (46.8% of CV deaths) and infection (54.2% of non-CV deaths) were the most common cause-specific deaths and did not vary by treatment strategy.
Conclusions: In ISCHEMIA-CKD, CV death was more common than non-CV or undetermined death during the 3-year follow-up. The randomized treatment assignment did not affect the cause-specific incidences of death in participants with advanced CKD and moderate or severe myocardial ischemia. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Chronic Kidney Disease [ISCHEMIA-CKD]; NCT01985360).
Gu L, Xia Z, Qing B, Wang W, Chen H, Wang J Front Immunol. 2024; 15:1338025.
PMID: 38558798 PMC: 10978803. DOI: 10.3389/fimmu.2024.1338025.
The potential association between influenza vaccination and lower incidence of renal cell carcinoma.
Marques da Silva B, Mayne K, Zakrocka I Clin Kidney J. 2023; 16(11):1714-1717.
PMID: 37915932 PMC: 10616471. DOI: 10.1093/ckj/sfad180.
ISCHEMIA-EXTEND studies: Rationale and design.
Anthopolos R, Maron D, Bangalore S, Reynolds H, Xu Y, OBrien S Am Heart J. 2022; 254:228-233.
PMID: 36206950 PMC: 9880872. DOI: 10.1016/j.ahj.2022.09.009.